News
Workday unlocks pricing power through AI-driven productivity and a more embedded role via ASOR. Check out why WDAY stock is ...
Day One Biopharmaceuticals' Ojemda sees $57.2M in 2024 sales amid biotech pullback. DAWN's stock is near 52-week lows. Read ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback